North China Pharmaceutical Co. Ltd. A | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,492.50
28,698.70
50,850.70
51,631.30
14,438.10
146
Depreciation, Depletion & Amortization
358,370.80
418,624.00
402,860.00
430,687.20
460,287.70
566
Other Funds
530,709.90
682,095.70
389,970.90
513,153.40
486,862.30
501
Funds from Operations
604,814.70
734,797.60
726,002.20
758,509.80
884,641.30
1,212
Changes in Working Capital
739,840.80
641,075.40
603,316.70
1,192,193.30
596,899.70
404
Net Operating Cash Flow
135,026.00
93,722.30
122,685.50
433,683.50
287,741.60
808
Capital Expenditures
560,944.30
262,166.00
367,811.50
288,594.30
399,691.50
Sale of Fixed Assets & Businesses
2,268.10
129.40
1,039.10
29,624.00
18,447.20
Purchase/Sale of Investments
995.00
61,754.50
-
-
200,000.00
Net Investing Cash Flow
536,681.30
323,791.10
366,772.40
309,892.60
581,244.20
Cash Dividends Paid - Total
51,007.40
-
-
32,616.10
32,616.10
Issuance/Reduction of Debt, Net
701,690.60
294,750.50
590,210.30
1,253,556.40
570,211.10
Net Financing Cash Flow
119,973.40
387,345.30
200,239.30
707,787.00
50,732.70
Net Change in Cash
553,555.90
158,820.60
34,193.80
29,491.00
250,867.40
Free Cash Flow
695,970.40
168,443.80
245,126.00
722,277.70
111,949.90
Deferred Taxes & Investment Tax Credit
15.20
820.70
196.50
271.10
1,851.80
-
Net Assets from Acquisitions
-
-
-
50,922.30
-
Other Sources
21,000.00
-
-
-
-
Exchange Rate Effect
1,821.90
1,544.20
9,653.80
6,298.10
8,097.50
About North China Pharmaceutical Co.
View Profile
